Anifrolumab (Saphnelo) Gets Green Light for Approval in EU Anifrolumab (Saphnelo) Gets Green Light for Approval in EU

Anifrolumab, a monoclonal antibody against type I interferon receptor, was approved by the US Food and Drug Administration in July 2021.International Approvals
Source: Medscape Rheumatology Headlines - Category: Rheumatology Tags: Dermatology News Alert Source Type: news